Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension

by Marzieh Nosrati, Nikinaz Ashrafi Shahmirzadi, Monireh Afzali, Pardis Zaboli, Hasti Rouhani, Haleh Hamedifar, Mirhamed Hajimiri
Published 2020-01-01